CD36 and melanoma: Consequently, blockade of CD36 by genetic ablation or by using neutralizing antibodies reduces FA uptake in tumor cells and dramatically impairs metastasis formation and cancer aggressiveness in a wide variety of cancers including melanoma (Pascual et al., 2017; Ladanyi et al., 2018; Deng et al., 2019; Jiang et al., 2019; Pan et al., 2019; Pfeiler et al., 2019; Wang and Li, 2019; Watt et al., 2019).